Adam King serves as Executive at QSAM Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Adam King has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 2, 2024 involved selling 11 shares valued at $0.
Adam King currently holds 22,950 shares of QSAM Biosciences, Inc. (QSAM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam King has been a net neutral trader of QSAM stock. They have purchased $0 and sold $0 worth of shares.
Adam King's most recent insider trade was on May 2, 2024, when they sold 11 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 23, 2023 | QSAM | $0 | Award | 20,910 | $N/A | Discretionary |